Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma Who Had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report

Su Jin Lee; Ho Sung Lee; Jae Sung Choi; Ju Ock Na; Ki Hyun Seo; Mi Hye Oh; Sung Shick Jou

首页> 外文期刊>Journal of Clinical Medicine Research >Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma Who Had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report

【24h】

Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma Who Had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report

机译：吉非替尼再治疗对初发吉非替尼治疗有良好疗效的患有鳞状上皮性腺癌的肺癌患者的显著疗效：一例报告

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Gefitnib is an oral agent of epidermal growth factor receptor tyrosine kinase inhibitor, and it has a certain efficacy against non-small cell lung cancer. There are some reports that the non-small cell lung cancer patients who experienced disease progression after responding to gefitinib were again sensitive to re-administration of gefitinib following temporary cessation of gefitinib. This is the case report showing a remarkable effect of gefitinib re-treatment in a patient with metastatic invasive adenocarinoma who had experienced favorable results from the initial treatment with gefitinib.doi:10.4021/jocmr816e

机译：吉非替尼是一种表皮生长因子受体酪氨酸激酶抑制剂的口服药物，对非小细胞肺癌具有一定的疗效。有报告指出，对吉非替尼有反应后经历疾病进展的非小细胞肺癌患者再次对吉非替尼的暂时停用后再次服用吉非替尼敏感。该病例报告显示，吉非替尼重新治疗对转移性浸润性腺癌患者具有显着疗效，该患者从使用吉非替尼的初始治疗中获得了良好的疗效。doi：10.4021 / jocmr816e

著录项

来源
《Journal of Clinical Medicine Research》 |2012年第3期|共5页
作者
Su Jin Lee; Ho Sung Lee; Jae Sung Choi; Ju Ock Na; Ki Hyun Seo; Mi Hye Oh; Sung Shick Jou;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. Retreatment of lung adenocarcinoma patients with gefitinib who had experienced favorable results from their initial treatment with this selective epidermal growth factor receptor inhibitor: a report of three cases. [J] . Yano S, Nakataki E, Ohtsuka S, Oncology Research . 2005,第2期

机译：吉非替尼治疗的肺腺癌患者从使用这种选择性表皮生长因子受体抑制剂的初始治疗中获得了良好的效果：三例报道。
2. Remarkable effect of gefitinib retreatment in a patient with nonsmall cell lung cancer who had a complete response to initial gefitinib. [J] . Yoshimoto A, Inuzuka K, Kita T, The American Journal of the Medical Sciences . 2007,第4期

机译：非小细胞肺癌对初始吉非替尼有完全反应的患者接受吉非替尼治疗的显着效果。
3. Gefitinib versus erlotinib as salvage treatment for lung adenocarcinoma patients who benefited from the initial gefitinib: A retrospective study [J] . YuS., WangY., LiJ., Thoracic cancer. . 2013,第2期

机译：吉非替尼与厄洛替尼作为从最初的吉非替尼中获益的肺腺癌患者的挽救性治疗：一项回顾性研究
4. Effects of Erlotinib after Acquired Resistance to Gefitinib in Advanced Non-small-cell Lung Cancer [C] . Pan Jingjing, Shi Meiqi, Feng Jifeng Biomedical Engineering and Biotechnology (iCBEB), 2012 International Conference on . 2012

机译：吉非替尼耐药对晚期非小细胞肺癌患者的厄洛替尼治疗效果
5. The cost effectiveness of screening for early stage lung cancer and the testing and treatment of molecular subgroups among non-small cell lung cancer patients in the province of ontario, canada [D] . Thao, Mallory. 2014

机译：加拿大安大略省非小细胞肺癌患者早期肺癌筛查的成本效益及分子亚群的检测和治疗
6. Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma who had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report [O] . Su Jin Lee, Ho Sung Lee, Jae Sung Choi, 2012

机译：吉非替尼再治疗对初发吉非替尼治疗有良好效果的鳞状上皮性腺癌的肺癌患者的显着疗效：一例报告
7. Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma who had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report [O] . Lee, Su Jin, Lee, Ho Sung, Choi, Jae Sung, 2012

机译：吉非替尼再治疗对初发吉非替尼治疗有良好效果的鳞状上皮性腺癌的肺癌患者的显着疗效：一例报告

Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma Who Had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report

摘要

著录项

相似文献

相关主题

期刊订阅